MOREPEN LABORATORIES
Back to Balance Sheet
|
MOREPEN LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹199 Cr | ₹90 Cr | ₹44 Cr | ₹37 Cr | ₹35 Cr |
What is the latest Total Non-Current Liabilities ratio of MOREPEN LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹199 Cr |
| Mar2025 | ₹90 Cr |
| Mar2024 | ₹44 Cr |
| Mar2023 | ₹37 Cr |
| Mar2022 | ₹35 Cr |
How is Total Non-Current Liabilities of MOREPEN LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹199 Cr | 119.62 | |
| Mar2025 | ₹90 Cr | 105.96 | |
| Mar2024 | ₹44 Cr | 19.11 | |
| Mar2023 | ₹37 Cr | 3.91 | |
| Mar2022 | ₹35 Cr | - | |
Compare Total Non-Current Liabilities of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹5,041.6 Cr | -14.9% | -37.3% | 103.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | 5.2% | 4.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹273,565.0 Cr | 3.6% | 7.6% | 50.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,332.0 Cr | 3.4% | 0.7% | 32.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,532.0 Cr | 2.3% | 14% | 13.6% | Stock Analytics | |
| CIPLA | ₹113,831.0 Cr | 2% | 6% | -6.7% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | -14.9% |
-37.3% |
103.3% |
| SENSEX | 8.8% |
10.9% |
-4% |
You may also like the below Video Courses